Polycystin-1L3 Activators represent a class of chemical compounds specifically designed to upregulate or enhance the expression of Polycystin-1L3, a protein encoded by the PKD1L3 gene. These compounds, while diverse in their chemical structures, share a common functional goal: to interact with the cellular and molecular pathways that control the expression of Polycystin-1L3. This interaction is primarily at the genetic or epigenetic level, influencing the transcriptional activity of the PKD1L3 gene. The mechanisms by which these activators function can vary significantly. Some may bind directly to regulatory regions of the gene, altering the affinity of transcription factors and thereby modulating gene expression. Others might interact indirectly by influencing signaling pathways that converge on the PKD1L3 gene, such as cAMP-dependent pathways or calcium signaling networks.
In terms of their chemical composition, Polycystin-1L3 Activators could encompass a range of molecules including small organic compounds, biologically active peptides (excluding proteins), or even synthetic analogs of naturally occurring substances. The specificity of these activators is a crucial aspect, as it determines their ability to selectively influence Polycystin-1L3 without affecting other proteins or pathways. This specificity is achieved through careful molecular design, often guided by detailed knowledge of the structure and function of Polycystin-1L3. The structural variety among these activators is vast, reflecting the diverse nature of the biochemical pathways they target. For instance, compounds that modulate second messenger systems might be structurally different from those affecting transcription factor binding. However, the underlying principle remains the same: to engage with the cell's own machinery in a way that results in increased levels of Polycystin-1L3 expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
May increase cAMP levels, potentially leading to upregulation of Polycystin-1L3 expression via cAMP-dependent pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Could upregulate Polycystin-1L3 expression through modulation of retinoid signaling pathways, influencing gene expression. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Might promote Polycystin-1L3 expression via its role in calcium homeostasis and signaling. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Known to activate Wnt signaling; might upregulate Polycystin-1L3 expression as part of this pathway. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Could enhance Polycystin-1L3 expression through estrogen receptor-mediated signaling pathways. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
May promote cellular processes leading to the upregulation of Polycystin-1L3 expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Could induce Polycystin-1L3 expression by influencing sirtuin pathways. | ||||||